SCHEMBL28207103

SCHEMBL28207103

NC(=O)c1ccccc1-c1ccc(-c2ccccc2F)nc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 8/20 0.62
ALOX5AP P20292 7/20 0.62
BCAT2 O15382 1/20 0.53
NPC1 O15118 3/20 0.51
RAB9A P51151 2/20 0.51
PARP1 P09874 2/20 0.46
DHODH Q02127 1/20 0.44
CDC7 O00311 1/20 0.44
HPGDS O60760 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CSNK1A1 P48729 1/20 0.43
TYRO3 Q06418 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28040903 0.88 FEN1 (0.54) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL28207188 0.82 ALOX5AP (0.46) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL18045627 0.80 FEN1 (0.44) FEN1ALOX5APNPC1RAB9APARP1
SCHEMBL2113823 0.78 NPC1 (0.59) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL920340 0.78 FEN1 (0.60) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL15916075 0.77 FEN1 (1.00) FEN1ALOX5AP
SCHEMBL21590306 0.76 BCAT2 (0.58) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL5878337 0.76 BCAT2 (0.87) FEN1ALOX5APBCAT2NPC1RAB9A
SCHEMBL30810190 0.76 BCAT2 (0.53) FEN1ALOX5APBCAT2PARP1CSNK1A1
SCHEMBL2567641 0.75 BCAT2 (0.71) FEN1ALOX5APBCAT2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105228982-B 3-acetylamino-1- (phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino) benzene derivatives for the treatment of hyperproliferative disorders 拜耳制药股份公司 2018-03-27 CN disclosed